BTG3 and Decreased liver function: At baseline, 18/44 (40.9%) patients had positive ANA titers, 5 (11.4%) patients had positive ENA measurements, 2 (4.5%) patients had positive hepatopathy antibody titers, and one patient had positive titers of antibodies associated with myositis.